What's Next for the LVAD Market?
Medtronic's purchase of HeartWare means both major LVAD companies have been snapped up by large cardiovascular players. What does this mean for the technology's future?
Analyst: Worldwide TAVR Market Worth $5.5B by 2020
As transcatheter aortic valve replacement moves from inoperable and high risk patients to patients who have moderate or lower risk for open heart surgery, the market will expand tremendously.
CGM Users Rely Less on Blood Glucose Meters
Dexcom presents data that shows patients with continuous glucose monitors use blood glucose meters less frequently, yet achieve tighter glucose control and have improved quality of life.
More on Medtronic's Answer to the S-ICD
The cardiac rhythm management company is developing a new, extravascular ICD that has leads placed outside the heart and vascular system. How is it different from the S-ICD?
NuVasive Doubles Down on Service Business
NuVasive picks up Biotronic NeuroNetwork, doubling its U.S. service business and resulting in the creation of the company's Clinical Services division.